Search
for
Sort by
Research 211–240 of 1000+
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Tregs: Where We Are and What Comes Next?
- Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease
- Oxidative Stress and Skin Diseases: The Role of Lipid Peroxidation
- Nanomedicine-based immunotherapy for tissue regeneration
- Cell death in skin function, inflammation, and disease
- Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease
- Editorial: Crosstalk: skin cells and immune cells in inflammatory skin diseases
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle
- Research Progress on the Immunomodulatory Effects by Dang Gui (Radix Angelica sinensis) and Its Active Chemical Components
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
- Revolutionizing Radiotoxicity Management with Mesenchymal Stem Cells and Their Derivatives: A Focus on Radiation-Induced Cystitis
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- THE USE OF TOFACITINIB IN THE TREATMENT OF IMMUNE-MEDIATED UNIVERSAL ALOPECIA IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT
- Evaluation of Serum Toll-Like Receptor 4, Interferon Gamma, and Interleukin-17 Levels in Iraqi Patients with Alopecia Areata
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- 1319 Claudin-1 and -3 maintain proper hair follicle structure and regulate telogen effluvium
- 1320 Orchestrated cytotoxic and skin migratory ability lacking self-tolerance: circulating γδT-cells may promote alopecia areata
- 1317 Nicotinic acid suppresses sebaceous lipid synthesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA2)
- Alopecia areata in 2 patients treated with dupilumab: New onset and worsening
- Dupilumab in a 9-week-old with Netherton Syndrome Leads to Deep Symptom Control
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Hidradenitis suppurativa: a new therapeutic approach for an old disease
- Latest Advances in Inflammatory Skin Disease
- The great atopic diseases epidemic: does chemical exposure play a role?
- 272 Structural changes in human skin after topical application of glucocorticoids assessed by in vivo imaging technologies
- 270 A novel small compound HPH-15 antagonizes TGF-β/Smad signaling and ameliorates experimental skin fibrosis
- 267 Deep phenotyping of patients with xeroderma pigmentosum and trichothiodystrophy
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review